KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ClearPoint Neuro (CLPT) Return on Sales (2018 - 2026)

ClearPoint Neuro's Return on Sales history spans 13 years, with the latest figure at 0.01% for Q4 2025.

  • On a quarterly basis, Return on Sales changed 0.0% to 0.01% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.01%, a 0.0% change, with the full-year FY2025 number at 0.01%, changed 0.0% from a year prior.
  • Return on Sales hit 0.01% in Q4 2025 for ClearPoint Neuro, down from 0.01% in the prior quarter.
  • Over the last five years, Return on Sales for CLPT hit a ceiling of 0.01% in Q1 2024 and a floor of 0.01% in Q2 2023.
  • Historically, Return on Sales has averaged 0.01% across 5 years, with a median of 0.01% in 2025.
  • Biggest five-year swings in Return on Sales: changed 0bps in 2021 and later rose 1bps in 2024.
  • Tracing CLPT's Return on Sales over 5 years: stood at 0.01% in 2021, then grew by 11bps to 0.01% in 2022, then increased by 20bps to 0.01% in 2023, then dropped by 0bps to 0.01% in 2024, then dropped by -8bps to 0.01% in 2025.
  • Business Quant data shows Return on Sales for CLPT at 0.01% in Q4 2025, 0.01% in Q3 2025, and 0.01% in Q2 2025.